Monoclonals
Ellsworth
About Monoclonals
Monoclonals develops novel monoclonal antibodies for rapid tests which diagnose diseases, specifically for resource poor areas. Founded in 2016 by Christine Soto, Monoclonals is currently registered with National Institute of Health (NIH) for the purpose of obtaining a grant which will help develop novel rapid test kits for diagnostic purposes. The company is privately funded and at product development phase.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $25.2K
- Funding stage: Seed
- Last round: Grant (Jan 2020)
- Website: monoclonalsin.com
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/monoclonals-188504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.